エルシニア診断市場の規模、シェア、成長分析、製品別、診断テスト別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

エルシニア診断の世界市場規模は2023年に34億7,000万米ドルと評価され、2024年の36億2,000万米ドルから2032年には50億3,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは4.2％で成長する見通しです。

世界のエルシニア診断市場は、エルシニア感染症の罹患率の上昇、診断ツールの技術進歩、早期発見の重要性に関する一般市民の意識の高まりなどを背景に、大きな成長が見込まれています。分子診断技術の採用が増加していることも、市場拡大を後押しする重要な要因です。さらに、食品を媒介とする疾病の流行やエルシニア症患者の世界の増加が市場需要に寄与しています。しかし、診断薬メーカー間の競合激化、ヘルスケアに対する政府資金の不十分さ、組織による大量調達などの課題が成長を阻害する可能性があります。北米、欧州、アジア太平洋は、政府のイニシアティブ、ヘルスケアインフラの強化、革新的な診断アッセイの開発などに支えられ、今後数年間の堅調な成長を保証する、市場に影響を与える主要地域です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩

エルシニア診断市場規模：製品別

• 市場概要
• 機器
• キットと試薬

エルシニア診断市場規模：診断テスト別

• 市場概要
• 便培養
• 画像検査
• 血清学的検査
• 大腸内視鏡検査
• ELISA
• 放射免疫測定
• チューブ凝集反応
• CTスキャン
• 超音波検査
• 大腸内視鏡検査
• その他

エルシニア診断市場規模：技術別

• 市場概要
• 免疫測定
• DNAプローブ
• ポリメラーゼ連鎖反応（PCR）
• フローサイトメトリー
• クロマトグラフィー
• その他

エルシニア診断市場規模：エンドユーザー別

• 市場概要
• 病院
• 公衆衛生研究所
• 商業研究所
• その他

エルシニア診断市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（USA）
• Thermo Fisher Scientific（USA）
• Bio-Rad Laboratories（USA）
• Hologic, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• QIAGEN N.V.（Netherlands）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Siemens Healthineers AG（Germany）
• bioMerieux SA（France）
• Merck KGaA（Germany）
• Lonza Group AG（Switzerland）
• Agilent Technologies, Inc.（USA）
• Illumina, Inc.（USA）
• bioAffinity Technologies, Inc.（USA）
• Gen-Probe Incorporated（USA）

結論と推奨事項

Global Yersinia Diagnostics Market size was valued at USD 3.47 billion in 2023 and is poised to grow from USD 3.62 billion in 2024 to USD 5.03 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global Yersinia diagnostics market is expected to experience significant growth driven by the rising incidence of Yersinia infections, technological advancements in diagnostic tools, and heightened public awareness regarding the importance of early detection. The increasing adoption of molecular diagnostic technologies is a crucial factor propelling market expansion. Additionally, the prevalence of food-borne diseases and a rise in yersiniosis cases globally are contributing to market demand. However, challenges such as intensified competition among diagnostic producers, inadequate government funding for healthcare, and bulk procurement by organizations may hinder growth. North America, Europe, and Asia Pacific are key regions influencing the market, supported by governmental initiatives, enhanced healthcare infrastructure, and the creation of innovative diagnostic assays, ensuring robust growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Yersinia Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Yersinia Diagnostics Market Segmental Analysis

Global Yersinia Diagnostics Market is segmented by Product, Diagnostic Test, Technology, End User and region. Based on Product, the market is segmented into Instruments and Kits and Reagents. Based on Diagnostic Test, the market is segmented into Stool Culture, Imaging Tests, Serological Tests, Colonoscopy, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy and Others. Based on Technology, the market is segmented into Immunoassay, DNA Probes, Polymerase Chain Reaction (PCR), Flow Cytometry, Chromatography and Others. Based on End User, the market is segmented into Hospitals, Public Health Laboratories, Commercial Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Yersinia Diagnostics Market

The global demand for Yersinia diagnostics is primarily driven by the increasing prevalence of Yersinia infections, particularly those caused by Yersinia enterocolitica and Yersinia pseudotuberculosis, which are notable contributors to foodborne illnesses and gastrointestinal disorders worldwide. The incidence rates of these infections fluctuate across different regions and over time; however, areas experiencing higher occurrences are generating significant needs for diagnostic solutions. Consequently, healthcare professionals and public health organizations are actively seeking reliable diagnostic tools to accurately detect and manage Yersinia infections, particularly as case numbers continue to rise, thereby fueling market growth in this sector.

Restraints in the Global Yersinia Diagnostics Market

The global Yersinia diagnostics market faces significant challenges due to the intricate nature of Yersinia infections. These infections can present a variety of nonspecific symptoms, such as diarrhea, abdominal pain, and fever, which overlap with those of other gastrointestinal disorders. This ambiguity complicates clinical diagnosis and can lead to misinterpretations, especially as Yersinia infections may also mimic conditions like appendicitis. Such difficulties in accurately and promptly identifying Yersinia infections can reduce the demand for diagnostic tests, thereby restraining market growth. Consequently, the complexity and nonspecific nature of these infections pose obstacles to effective diagnosis and treatment.

Market Trends of the Global Yersinia Diagnostics Market

The Global Yersinia Diagnostics market is experiencing a significant shift towards molecular diagnostic methods, marking a key trend in the industry. The adoption of advanced technologies like polymerase chain reaction (PCR) assays and nucleic acid amplification tests (NAATs) is on the rise, primarily due to their superior sensitivity, specificity, and reduced turnaround times compared to traditional culture-based techniques. These molecular methods enable the rapid and accurate detection of Yersinia DNA in clinical specimens, enhancing diagnostic capabilities. Consequently, healthcare providers and laboratories are increasingly investing in these advanced platforms, propelling the growth of the Yersinia diagnostics market as they strive for quicker and more reliable pathogen identification.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Yersinia Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits and Reagents

Global Yersinia Diagnostics Market Size by Diagnostic Test & CAGR (2025-2032)

• Market Overview
• Stool Culture
• Imaging Tests
• Serological Tests
• Colonoscopy
• ELISA
• Radioimmunoassay
• Tube Agglutination
• CT Scan
• Ultrasonography
• Colonoscopy
• Others

Global Yersinia Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Immunoassay
• DNA Probes
• Polymerase Chain Reaction (PCR)
• Flow Cytometry
• Chromatography
• Others

Global Yersinia Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Public Health Laboratories
• Commercial Laboratories
• Others

Global Yersinia Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Diagnostic Test, Technology, End User)
  • US
  • Canada
• Europe (Product, Diagnostic Test, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Diagnostic Test, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Diagnostic Test, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Diagnostic Test, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioAffinity Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gen-Probe Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations